文献速递血栓与止血

凝血因子VIII抑制的结构基础揭示C1结构域上共享的抗原热点

Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain.
PubMed 文献 · J Thromb Haemost · 2024-06-05

本研究通过冷冻电镜解析了FVIII与LE2E9重组构建体NB2E9的Fab片段复合物的3.46 Å结构,表位涉及FVIII残基S2040至Y2043、K2065至W2070和R2150至H2155。该表位与鼠源抑制剂2A9的表位部分重叠,提示FVIII-/-小鼠与血友病A患者间存在共享抗原区域,且LE2E9聚糖可空间阻碍FVIII C1结构域与血管性血友病因子D'结构域的相互作用。

要点

  • FVIII与NB2E9复合物冷冻电镜结构分辨率为3.46 Å。
  • LE2E9表位涵盖FVIII残基S2040-Y2043、K2065-W2070和R2150-H2155。
  • LE2E9聚糖可空间阻碍FVIII C1结构域与血管性血友病因子D'结构域结合。

核心结论

  • 结果描述了FVIII C1结构域上的抗原热点,为工程化降低抗原性的FVIII替代疗法提供了结构基础。

研究设计与样本

  • FVIII与NB2E9的Fab片段结合,通过冷冻电镜测定复合物结构。

主要发现

  • FVIII与NB2E9复合物结构分辨率为3.46 Å,其表位包含FVIII残基S2040至Y2043、K2065至W2070和R2150至H2155。
  • LE2E9表位与鼠源抑制剂2A9的表位部分重叠,提示这些残基代表FVIII-/-小鼠与血友病A患者之间在C1结构域上的共享抗原区域。
  • FVIII:NB2E9结构阐明了LE2E9聚糖的取向,说明该聚糖如何空间阻碍FVIII C1结构域与血管性血友病因子D'结构域之间的相互作用。
  • FVIIIa:FIXa复合物的推测模型提示NB2E9聚糖与FIXa轻链之间可能存在碰撞。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hemophilia A arises from dysfunctional or deficient coagulation factor (F)VIII and leads to inefficient fibrin clot formation and uncontrolled bleeding events. The development of antibody inhibitors is a clinical complication in hemophilia A patients receiving FVIII replacement therapy. LE2E9 is an anti-C1 domain inhibitor previously isolated from a mild/moderate hemophilia A patient and disrupts FVIII interactions with von Willebrand factor and FIXa, though the intermolecular contacts that underpin LE2E9-mediated FVIII neutralization are undefined. OBJECTIVES: To determine the structure of the complex between FVIII and LE2E9 and characterize its mechanism of inhibition. METHODS: FVIII was bound to the antigen binding fragment (Fab) of NB2E9, a recombinant construct of LE2E9, and its structure was determined by cryogenic electron microscopy. RESULTS: This report communicates the 3.46 Å structure of FVIII bound to NB2E9, with its epitope comprising FVIII residues S2040 to Y2043, K2065 to W2070, and R2150 to H2155. Structural analysis reveals that the LE2E9 epitope overlaps with portions of the epitope for 2A9, a murine-derived inhibitor, suggesting that these residues represent a shared antigenic region on the C1 domain between FVIII-/- mice and hemophilia A patients. Furthermore, the FVIII:NB2E9 structure elucidates the orientation of the LE2E9 glycan, illustrating how the glycan sterically blocks interactions between the FVIII C1 domain and the von Willebrand factor D' domain. A putative model of the FVIIIa:FIXa complex suggests potential clashing between the NB2E9 glycan and FIXa light chain. CONCLUSION: These results describe an antigenic "hotspot" on the FVIII C1 domain and provide a structural basis for engineering FVIII replacement therapeutics with reduced antigenicity.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Childers KC, Cowper B, Vaughan JD, et al. Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain. J Thromb Haemost. 2024. PMID: 38849084. doi:10.1016/j.jtha.2024.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。